India’s Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO
HYDERABAD (Reuters) – Indian drugmaker Glenmark Life Sciences posted a 13% rise in third-quarter profit on Tuesday, helped by a robust performance by its core active pharmaceutical ingredient (API) business. The Mumbai-based company, which detergent maker Nirma is in the process of taking over, said its profit rose to 1.19 billion rupees ($14.32 million) in …
India’s Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO Read More »